 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 4 | 1/1 | 返回列表 |
| 查看: 1222 | 回復(fù): 3 | |||
| 本帖產(chǎn)生 1 個 翻譯EPI ，點(diǎn)擊這里進(jìn)行查看 | |||
xiaotongxyz木蟲 (正式寫手)
|
[交流]
求助翻譯中文摘要一份，重賞金幣，翻譯的好可追加
|
||
|
原文： 國產(chǎn)利培酮治療腦血管病所致精神障礙療效分析 摘要：目的：探討國產(chǎn)利培酮（思利舒）治療腦血管病所致精神障礙療效和安全性。方法：隨機(jī)抽取腦血管病所致精神障礙30例，用思利舒治療，并分別于治療前及治療后第1、2、4、8周末才去簡明精神病量表（BPRS)、陽性癥狀陰性癥狀量表（PANSS）及副作用量表（TCSS）評定臨床療效及不良反應(yīng)。結(jié)果：BPRS總分、PANSS總分和各癥狀評分均較治療前顯著降低，且有顯著差異（P<0.01~0.05），有效率：90%，顯效率：63%，常見不良反應(yīng)是體重增加、靜坐不能。結(jié)論：思利舒對腦血管所知精神障礙安全有效，不良反應(yīng)少，經(jīng)濟(jì)適用，值得臨床推廣使用。 |
回復(fù)此樓» 猜你喜歡
317求調(diào)劑
已經(jīng)有12人回復(fù)
-
一志愿武漢理工材料工程專碩調(diào)劑
已經(jīng)有9人回復(fù)
-
【考研調(diào)劑】化學(xué)專業(yè) 281分，一志愿四川大學(xué)，誠心求調(diào)劑
已經(jīng)有7人回復(fù)
-
324求調(diào)劑
已經(jīng)有5人回復(fù)
-
288求調(diào)劑
已經(jīng)有16人回復(fù)
-
317求調(diào)劑
已經(jīng)有9人回復(fù)
-
287求調(diào)劑
已經(jīng)有8人回復(fù)
-
一志愿 西北大學(xué) ，070300化學(xué)學(xué)碩，總分287，雙非一本，求調(diào)劑。
已經(jīng)有4人回復(fù)
-
求調(diào)劑，一志愿:南京航空航天大學(xué)大學(xué) ，080500材料科學(xué)與工程學(xué)碩，總分289分
已經(jīng)有4人回復(fù)
-
085600材料與化工
已經(jīng)有8人回復(fù)
非比尋常
木蟲 (小有名氣)
- 翻譯EPI: 13
- 應(yīng)助: 0 (幼兒園)
- 金幣: 5037.7
- 散金: 888
- 帖子: 163
- 在線: 375.5小時
- 蟲號: 894506
- 注冊: 2009-11-05
- 性別: GG
- 專業(yè): 污染生態(tài)化學(xué)
xiaotongxyz(金幣+20, 翻譯EPI+1):翻譯的不夠?qū)I(yè)，有些翻譯不夠準(zhǔn)確專業(yè) 2010-04-30 01:18
|
Analysis of therapeutic effect of domestic Risperidone on non-psychotic disorders resulting from cerebrovascular diseases Abstract: Purpose: to probe into therapeutic effect and security of domestic Risperidone on non-psychotic disorders resulting from cerebrovascular diseases. Approach: to randomly draw 30 cases with non-psychotic disorders resulting from cerebrovascular diseases, treat them with Risperidone and then assess clinical curative effects and undesirable reactions with BPRS, PANSS and TCSS at the end of the first, second, fourth and eighth week before and after treatment. Result: aggregate score of BPRS and PANSS and each symptom score are considerablely much lower than that before treatment with significant variation (P<0.01~0.05). The effective rate is 90% and developing rate is 63%. Common undesirable reactions are gain in weight and loss of sitting still. Conclusion: Risperidone is secure and effective with a few undesirable reactions and deserves promotion and application because of its economically affordable and applicable trait on the treatment of non-psychotic disorders resulting from cerebrovascular diseases. |
2樓2010-04-29 21:53:09
pharmjackie
木蟲 (正式寫手)
- 翻譯EPI: 21
- 應(yīng)助: 2 (幼兒園)
- 金幣: 2210
- 帖子: 312
- 在線: 180.4小時
- 蟲號: 302356
- 注冊: 2006-12-02
- 性別: GG
- 專業(yè): 有機(jī)合成
xiaotongxyz(金幣+30):前半部分翻譯很好，后半部分不夠理想，專業(yè)性再強(qiáng)些就好了 2010-04-30 01:22
|
efficacy of Risperidone on brain vascular diseases caused psychonosema Abstract Object: to evaluate the efficacy and safety of Risperidone on brain vascular diseases caused psychonosema. Method: A total of 30 patients with psychonosema was randomly selected to treat with Risperidone, and clinical efficacy and adverse effect was recorded using BPRS, PANSS, and TCSS before treatment and at the end of 1, 2, 4, 8 weeks after treatment. Results: BPRS scores, PANSS scores and symptom scores decreased significantly compared to that of pre-treatment (P<0.01~0.05). Effective percentage is 90% while the obvious effective rate is 63%. Common adverse effects include: Weight gain, akathisia. Conclusion: Risperidone’s effectiveness, safety and minor adverse effect makes itself worthy of clinical use. |
3樓2010-04-29 22:10:21
xiaotongxyz
木蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 2121.1
- 散金: 10
- 紅花: 1
- 帖子: 380
- 在線: 11.3小時
- 蟲號: 325960
- 注冊: 2007-03-17
- 性別: GG
- 專業(yè): 蛋白質(zhì)組學(xué)
4樓2010-05-07 11:58:31
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 xiaotongxyz 的主題更新
| 4 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿南昌大學(xué)，327分，材料與化工085600 +8 | Ncdx123456 2026-03-19 | 8/400 |
|
|---|---|---|---|---|
|
[考研] 329求調(diào)劑 +9 | 想上學(xué)吖吖 2026-03-19 | 9/450 |
|
|
|
[考研] 260求調(diào)劑 +3 | 朱芷琳 2026-03-20 | 3/150 |
|
|
|
[考研] 353求調(diào)劑 +3 | 拉鉤不許變 2026-03-20 | 3/150 |
|
|
|
[考研] 085700資源與環(huán)境308求調(diào)劑 +11 | 墨墨漠 2026-03-18 | 12/600 |
|
|
|
[考研] 261求B區(qū)調(diào)劑，科研經(jīng)歷豐富 +3 | 牛奶很忙 2026-03-20 | 4/200 |
|
|
|
[考研] 求調(diào)劑 +3 | eation27 2026-03-20 | 3/150 |
|
|
|
[考研] 299求調(diào)劑 +3 | shxchem 2026-03-20 | 4/200 |
|
|
|
[考研] 298-一志愿中國農(nóng)業(yè)大學(xué)-求調(diào)劑 +9 | 手機(jī)用戶 2026-03-17 | 9/450 |
|
|
|
[考研] 0703化學(xué)調(diào)劑 +10 | 妮妮ninicgb 2026-03-15 | 14/700 |
|
|
|
[考研] 294求調(diào)劑材料與化工專碩 +14 | 陌の森林 2026-03-18 | 14/700 |
|
|
|
[考研] 材料專業(yè)求調(diào)劑 +5 | hanamiko 2026-03-18 | 5/250 |
|
|
|
[考研] 【同濟(jì)軟件】軟件（085405）考研求調(diào)劑 +3 | 2026eternal 2026-03-18 | 3/150 |
|
|
|
[考研] 材料專碩306英一數(shù)二 +10 | z1z2z3879 2026-03-16 | 13/650 |
|
|
|
[考研] 268求調(diào)劑 +6 | 簡單點(diǎn)0 2026-03-17 | 6/300 |
|
|
|
[基金申請]
今年的國基金是打分制嗎？
 50+3
|
zhanghaozhu 2026-03-14 | 3/150 |
|
|
|
[考研] 中科院材料273求調(diào)劑 +4 | yzydy 2026-03-15 | 4/200 |
|
|
|
[考研] 26考研一志愿中國石油大學(xué)(華東)305分求調(diào)劑 +3 | 嘉年新程 2026-03-15 | 3/150 |
|
|
|
[考研] 080500，材料學(xué)碩302分求調(diào)劑學(xué)校 +4 | 初識可樂 2026-03-14 | 5/250 |
|
|
|
[考研] 一志愿哈工大材料324分求調(diào)劑 +5 | 閆旭東 2026-03-14 | 5/250 |
|